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Protocol
AbstrACt
Introduction Small bowel obstruction (SBO) is a common 
indication for emergency laparotomy in the UK, which is 
associated with a 90-day mortality rate of 13%. There are 
currently no UK clinical guidelines for the management 
of this condition. The aim of this multicentre prospective 
cohort study is to describe the burden, variation in 
management and associated outcomes of SBO in the UK 
adult population.
Methods and analysis UK hospitals providing 
emergency general surgery are eligible to participate. 
This study has three components: (1) a clinical preference 
questionnaire to be completed by consultants providing 
emergency general surgical care to assesses preferences 
in diagnostics and therapeutic approaches, including 
laparoscopy and nutritional interventions; (2) site resource 
profile questionnaire to indicate ease of access to 
diagnostic services, operating theatres, nutritional support 
teams and postoperative support including intensive care; 
(3) prospective cohort study of all cases of SBO admitted 
during an 8-week period at participating trusts. Data on 
diagnostics, operative and nutritional interventions, and in-
hospital mortality and morbidity will be captured, followed 
by data validation.
Ethics and dissemination This will be conducted 
as a national audit of practice in conjunction with 
trainee research collaboratives, with support from 
patient representatives, surgeons, anaesthetists, 
gastroenterologists and a clinical trials unit. Site-specific 
reports will be provided to each participant site as well 
as an overall report to be disseminated through specialist 
societies. Results will be published in a formal project 
report endorsed by stakeholders, and in peer-reviewed 
scientific reports. Key findings will be debated at a focused 
national meeting with a view to quality improvement 
initiatives.
bACkground
Mechanical small bowel obstruction (SBO) 
is a common presentation to emergency 
general surgery. Eleven and a half thousand 
patients in England and Wales underwent 
emergency laparotomy for SBO during the 
12 months from April 2014 to March 2015.1 
This was associated with a 90-day mortality 
rate of 13%.1 Similar findings have been 
noted in the USA.2
SBO has several aetiologies, including 
congenital or postoperative adhesions, 
abdominal wall hernia and malignancy. Plain 
film radiography or CT may be used to confirm 
the diagnosis and determine underlying 
cause. Depending on aetiology and comor-
bidities, patients may be selected for early 
surgical intervention or conservative manage-
ment, typically with nasogastric decompres-
sion, urinary catheterisation and intravenous 
fluid therapy.3 4 Around two-thirds of patients 
managed conservatively for adhesive SBO 
will settle, but the remainder will require 
surgery,5 with a prolonging of the treatment 
pathway and time to gastrointestinal recovery 
(figure 1).
strengths and limitations of this study
 ► This study will be the largest prospective assessment 
of the management of small bowel obstruction in 
adults in the UK.
 ► This study will highlight variation in resources and 
clinical practice, and assess the impact of variation 
on patient outcomes.
 ► The methodology limits data to easily measured 
key components of the treatment pathway that are 
routinely captured in patient notes.
 ► Accuracy of data  collection will be assessed in a 
short post hoc validation exercise.
 ► Potential inclusion of all hospitals providing 
emergency general surgery will ensure that findings 
are broadly representative of UK practice.
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Guidelines already exist in the USA and Europe for the 
management of SBO.3 4 The Royal College of Surgeons 
of England has described a pathway for the management 
of SBO, although this is presented in guidelines for the 
commissioning of emergency services, rather than clin-
ical guidelines.6 This advocates the use of early CT scan-
ning, use of Gastrografin and timely intervention. Limited 
specific guidance leads to variation in the management of 
SBO across the UK.
Currently available data do not provide a national over-
view of the management of SBO: the National Emergency 
Laparotomy Audit (NELA) captures only the subset of 
patients who undergo surgery, meaning that we have no 
high-quality information on those managed conservatively 
and their outcomes.1 As SBO accounts for half of emer-
gency laparotomies, and likely many more conservatively 
managed patients, data to inform policy, quality improve-
ment programmes and clinical trials are an audit priority.7 8
AIM
The aim of this study is to describe the variation in 
management and outcomes of SBO in the UK.
Objectives of the study are to describe:
 ► variations in consultant practice in the management 
of SBO;
 ► variation in resources available to support the manage-
ment of SBO;
 ► patient pathways and variation in the management of 
SBO;
 ► use of diagnostics in SBO (CT, plain film radiography);
 ► interventions used in SBO (operative intervention, 
therapeutic trial of water-soluble contrast agent);
 ► use of nutritional assessment tools and resulting nutri-
tional interventions;
 ► rate of in-hospital mortality in patients treated for 
SBO;
 ► rates of 30-day readmission following treatment for 
SBO;
 ► rates of unplanned escalation to intensive care.
MEthods
This project has three components: a survey of clinical 
practice, a site resource questionnaire and a prospective 
cohort study (figure 2). Site recruitment has been under-
taken through specialty association conferences and elec-
tronic mailing, recruitment presentations at specialty 
meetings, through trainee research collaboratives and 
through professional contacts. All UK hospitals providing 
emergency general surgery are eligible to participate. 
This project has been registered with the Healthcare 
Quality Improvement Partnership.
survey of clinical practice
An anonymous survey of clinical practice has been 
prepared. This is to be completed only by consultant 
surgeons who provide emergency general surgery care—
these clinicians are ultimately responsible for the inpa-
tient management of this group and their preferences 
should influence care rather than other grades of doctor 
or other specialties. This captures basic demographic 
data including specialty and year of graduation. To 
contextualise clinical data, respondents are asked to indi-
cate the impact of specific clinical factors on the selection 
of primary operative or conservative management (eg, 
multilevel obstruction due to disseminated malignancy, 
raised or normal inflammatory markers), the minimum 
investigations required for management, use of Gastro-
grafin and use of laparoscopy. The survey also investigates 
preferences around nutritional support in SBO. Based on 
previous experience of surveying surgeons in areas with 
limited guidance, concerns have been expressed about 
providing responses out of line with the majority of the 
profession. In order to maximise returns, we decided to 
make this anonymous. This means that we cannot link 
back to institutions.
Figure 1 Conceptual schematic of pathways in the 
management of small bowel obstruction, including typical 
diagnoses and nutritional outcomes. TPN, total parenteral 
nutrition.
Figure 2 Components of NASBO (National Audit of Small 
Bowel Obstruction) study, and how they are related. BMI, 
body mass index.
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site resource profile
The site resource profile is to be completed once for each 
participating site. This captures data on staffing levels, 
ease of access to diagnostics, theatres and nutritional 
support teams. This will indicate frequency of handovers 
of care and delays in access to diagnostics: these factors 
that may delay decision-making for these patients. Access 
to theatres, intensive care and nutritional support teams 
will indicate resource for implementing these decisions. 
The questionnaire also assesses availability of resources 
on weekdays, weekends and overnight.
Prospective cohort study
Patients eligible for inclusion in the prospective cohort 
study must have met the following criteria:
 ► have been admitted from the emergency department 
or primary care to the acute surgery team or referred 
from an inpatient team to the emergency surgery 
team;
 ► a clinical diagnosis of SBO made by a specialty trainee 
year 3 or higher in general surgery.
These inclusion criteria are purposefully broad with 
the intention of capturing as many patients with SBO as 
possible.
Patients will be excluded if:
 ► they have undergone abdominal surgery within the 
same hospital admission prior to first symptoms of 
SBO;
 ► they are pregnant;
 ► they are under the age of 16 years old;
 ► they have large bowel obstruction (even when signs 
of SBO are present), for example, obstructing rectal 
tumour;
 ► they have length of stay <24 hours (discharged home).
Where the initial diagnosis changes, patients will be 
excluded retrospectively. Patients will be identified over an 
8-week period. This period has been selected based on pilot 
data and NELA reports—to ensure a representative sample 
of cases and facilitate meaningful analysis, we set a target 
of 1500 cases. Extrapolation of numbers from a multisite 
pilot suggested that >2000 cases would be identified during 
a 2-week period, with an exclusion rate of around 20%. 
Consideration was also given to rotation of junior medical 
staff, who undertake the majority of data collection, and 
the period avoids most rotation dates. Data to be captured 
include basic demographics, comorbidities in the form of 
the Charlson comorbidity index9 and usual place of resi-
dence (own home, residential home, nursing home) as 
a proxy for frailty (online supplementary appendix 1). 
Height and weight are captured to calculate body mass 
index (BMI) and nutritional risk index as risk adjustment 
tools.10
Data will be recorded on initial and final management 
strategies, baseline physiology, diagnostics and nutritional 
support strategies.
The primary outcome is in-hospital mortality. Secondary 
outcomes include in-hospital morbidity, length of stay 
and 30-day readmission.
Data will be uploaded to an encrypted and pass-
word-protected secure REDCap (Research Electronic 
Data Capture) server, hosted at the University of Shef-
field.11 No identifiable data are uploaded. Collaborators 
will keep a local ‘key’ spreadsheet linking REDCap identi-
fiers to NHS or Hospital Numbers on their NHS network.
Data validation
Only data sets with >95% data completeness will be 
accepted. Doctors at core trainee level or above, who were 
not involved in initial data collection, will act as indepen-
dent assessors, reviewing data collected at a local centre. 
Overall independent assessors will validate a minimum of 
10% of patient records, with a target of >95% case ascer-
tainment and >90% data accuracy.
The number of identified patients having surgery 
during the audit period will be compared with those 
recorded in the NELA database for the same period. This 
will give an indication of how representative the data set 
is.
Pilot
The survey has undergone pilot at two separate sites, with 
minor revisions after each round.
The prospective audit and site profile questionnaire 
have undergone a 2-week pilot across eight UK centres 
to confirm acceptability of definitions and usability of 
REDCap system.
Anticipated recruitment
Based on NELA data for 2014–20151 and pilot work, we 
anticipate mean identification rates of three cases/week 
per centre. Across 100 centres, anticipated recruitment 
would be 2400 cases.
Statistical analysis
Analysis will be performed by a statistician at the Clinical 
Trials Research Unit, University of Sheffield. Descrip-
tive analysis will be performed to describe crude rates 
of mortality and morbidity, with subgroup analysis of 
primary operation, conservative management and failed 
conservative management. BMI, nutritional risk index10 
and Charlson comorbidity index9 will be used for risk 
adjustment. Descriptive reporting of the use of diagnos-
tics, operative approach and nutritional support in the 
treatment pathway will be performed, and association 
with outcomes recorded.
Variation in patient characteristics was taken into 
account during study design and will be taken into 
account during statistical analysis. Due to the expected 
heterogeneity across all patients, only clinically valid 
comparisons will be made according to the care pathways 
outlined in figure 1 (ie, initial operative management, 
successful conservative management or failed conserva-
tive management). During statistical analysis, multilevel 
modelling will allow differences across centres to be taken 
into account. Multilevel logistic regression models will be 
constructed using clinically plausible variables to iden-
tify predictors of mortality and morbidity following SBO. 
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Effects of predictor variables will be presented as OR, 
alongside the corresponding 95% CI. Sensitivity analyses 
stratified by number of cases per centre (in the case where 
hospitals have fewer than five cases) will be performed to 
assess and identify any changes to the direction and effect 
size which may be influenced by the inclusion of centres 
with few cases.
Data will be matched to site resource profiles to 
assess the relationship between resource availability and 
management practices.
Ethics and governance
This project has been assessed by the Scientific Officer 
of the South East Scotland Research Ethics Service, 
who confirmed that the project did not require ethical 
approval. All sites must secure local audit approval prior 
to collecting data, and Information Governance or Cald-
icott approval prior to uploading data to REDCap. Cald-
icott approval for Scotland will be secured through a 
single central application.
Funding
This project has received funding from the Bowel Disease 
Research Foundation, Association of Coloproctology of 
Great Britain and Ireland, Association of Surgeons of 
Great Britain & Ireland, Association of Upper Gastro-
intestinal Surgeons, British Association of Parenteral 
and Enteral Nutrition, British Association for Surgical 
Oncology, British Society of Gastroenterology, Royal 
College of Surgeons of England, Royal College of Surgeon 
of Edinburgh, NELA and Royal College of Anaesthetists.
Authorship
All collaborators returning complete and validated 
data sets within the timelines will be eligible for collab-
orative authorship. This will be reported in line with the 
CRediT taxonomy.12 We intend that each site has no more 
than four collaborators.
dIsCussIon
SBO carries significant morbidity and mortality; however, 
most work on this topic has focused on specific diagnostic 
or therapeutic interventions, with little focus on how to 
address the associated high levels of mortality. The guid-
ance from Eastern Association for the Surgery of Trauma, 
and World Society for Emergency Surgery offers exten-
sive information on the use of CT scans to identify stran-
gulation or ‘high grade’ SBO and the selection of patients 
for surgery (and operative approach), or conservative 
management.3 4 This guidance does not substantially 
address other issues such as nutritional interventions, use 
of total parenteral nutrition or considerations in postop-
erative care.
This study will deliver the largest prospective assess-
ment of the management of SBO in adults in the UK. 
Using clinical data on management of SBO, clinician 
management preferences and a local resource profile, 
we will report variation in management of this condition. 
These data will also permit early exploration of factors 
associated with variation in practice, and their relation-
ship to outcomes. This study will also provide prelim-
inary data on interventions used in SBO to re-establish 
feeding. Other studies in the field have focused only on 
specific areas of SBO management and to our knowledge, 
there are very limited data with regard to how nutrition is 
handled. The central aim of the NASBO (National Audit 
of Small Bowel Obstruction) project is to address this by 
delivering high-quality data across multiple centres.
This project uses multiple methods to accumulate data 
including surveys and clinical data collection. Surveys 
have been carefully designed and piloted to ensure 
validity and clarity of questions.
The snapshot clinical data capture has been designed 
to capture key components of the SBO pathway. While 
it captures several key nodes of clinical practice, it does 
not report on the use of nasogastric tubes or use of intra-
venous fluids. While these are commonly used, accurate 
data capture to describe them would require a significant 
amount of resource for what is likely to be highly gran-
ular data. If required, these factors could be explored 
in future studies delivered by the NASBO network. 
The treatment pathway and pathophysiology of SBO is 
complex and varied. This complexity, however, must be 
balanced with the ability to deliver high-quality useable 
data. This balance has been emphasised when designing 
the study and developing data collection tools.
Trainee research collaboratives have previously 
demonstrated the ability to deliver large multicentre 
studies.13 14 This study differs in that it is the first time 
UK trainee research collaboratives have partnered with 
a number of specialty organisations and policymakers. 
The complexity of patient pathways and variation in 
clinical decision-making make SBO a prime target for 
intervention. Use and timing of CT, nutritional support 
and surgical intervention are all potentially costly 
interventions which are accompanied with risks to the 
patient. Therefore, it is imperative to generate a high-
quality evidence base in a condition which carries a 
high mortality and morbidity rate. High-quality data on 
SBO will also allow appropriate assessment of the health 
economic impact of future interventions. Findings of 
this study will be used to inform development of clin-
ical guidelines, quality indicators, and support develop-
ment of clinical trials in the field.
We envisage this project will allow a network to be 
formed by clinicians who have an interest in improving 
outcomes following SBO. This network will permit the 
delivery of quality improvement projects and further, 
interventional research studies to be performed based on 
the results of the inaugural NASBO study.
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